Recall
FDAHealthJanuary 30, 2026

Tandem Diabetes Care, Inc. — Tandem pumps are battery-operated infusion pumps capable of both basal and bolus delivery of insulin. The pumps utilize a motor-driven mechanism to deliver insulin from wi

⚠️ The Czech language user guide contained multiple translation errors. The most significant error was that it incorrectly instructs users to verify that the infusion set is connected to the body, when it should instead direct users to confirm that the infusion set is not connected to the body. Following this instruction could result in unintended insulin delivery, potentially leading to a hypoglycemic event.

Is this relevant to me?

Geography
Unknown
Source agency
FDA
Category
Health
Published
January 30, 2026

International distribution in the countries of Czech Republic, Slovakia.

What's affected?

Product
Tandem pumps are battery-operated infusion pumps capable of both basal and bolus delivery of insulin. The pumps utilize a motor-driven mechanism to deliver insulin from within a disposable cartridge, through an infusion set, into a patient s subcutaneous tissue. As with current insulin infusion pumps on the U.S. market, the desired timing and quantity of the insulin delivery is programmed by the user (i.e., the patient).
Lot code
Version 7.8.1/ UDI: (01)008500066132625

Additional details

Version 7.8.1/ UDI: (01)008500066132625

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 1,380 units.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.